4//SEC Filing
Osborne Matthew Scott 4
Accession 0001209191-19-038965
CIK 0001622229other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 4:51 PM ET
Size
5.5 KB
Accession
0001209191-19-038965
Insider Transaction Report
Form 4
Osborne Matthew Scott
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-06-24+190,000→ 190,000 totalExercise: $2.44Exp: 2029-06-24→ Common Stock (190,000 underlying)
Footnotes (1)
- [F1]This stock option shall vest as follows: 25% on the first anniversary of the date of grant then in equal monthly installments over 36 months.
Documents
Issuer
Unum Therapeutics Inc.
CIK 0001622229
Entity typeother
Related Parties
1- filerCIK 0001780543
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 4:51 PM ET
- Size
- 5.5 KB